Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $2,827 | 1 | 98.0% |
| Food and Beverage | $57.64 | 4 | 2.0% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Innovative Medical Technologies, LLC | $2,827 | 6 | $0 (2021) |
| Bausch Health US, LLC | $57.64 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $57.64 | 5 | Bausch Health US, LLC ($57.64) |
| 2020 | $0 | 1 | Innovative Medical Technologies, LLC |
| 2019 | $0 | 1 | Innovative Medical Technologies, LLC |
| 2018 | $0 | 1 | Innovative Medical Technologies, LLC |
| 2017 | $2,827 | 2 | Innovative Medical Technologies, LLC ($2,827) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/09/2021 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Neurology | ||||||
| 06/09/2021 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Neurology | ||||||
| 05/27/2021 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Neurology | ||||||
| 05/06/2021 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Neurology | ||||||
| 2021 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 2020 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 2019 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 2018 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 05/11/2017 | Innovative Medical Technologies, LLC | — | Current or prospective ownership or investment interest | Stock option | $2,826.61 | General |
| 2017 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 44 | 47 | $6,148 | $1,206 |
| 2021 | 7 | 350 | 615 | $93,397 | $44,333 |
| 2020 | 10 | 387 | 673 | $102,078 | $40,894 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 34 | $6,018 | $1,167 | 19.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 13 | $130.00 | $39.00 | 30.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 319 | $56,463 | $25,907 | 45.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 75 | 75 | $20,100 | $9,752 | 48.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 32 | $7,648 | $4,516 | 59.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 29 | 29 | $2,320 | $1,893 | 81.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 31 | $3,720 | $1,459 | 39.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 32 | 32 | $2,176 | $518.08 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 73 | 97 | $970.00 | $288.76 | 29.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 98 | 347 | $61,419 | $23,640 | 38.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 64 | 64 | $17,152 | $7,277 | 42.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 27 | $6,453 | $2,633 | 40.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 34 | 35 | $2,800 | $2,061 | 73.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 12 | 12 | $4,560 | $1,960 | 43.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 13 | 13 | $2,080 | $1,525 | 73.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 28 | $3,360 | $737.95 | 22.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 33 | 35 | $2,380 | $561.49 | 23.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 78 | 99 | $990.00 | $290.94 | 29.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 13 | 13 | $884.00 | $207.31 | 23.5% |
About Dr. Michael Maggio, MD
Dr. Michael Maggio, MD is a Internal Medicine healthcare provider based in Stow, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225072325.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Maggio, MD has received a total of $2,884 in payments from pharmaceutical and medical device companies, with $57.64 received in 2021. These payments were reported across 10 transactions from 2 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($2,827).
As a Medicare-enrolled provider, Maggio has provided services to 781 Medicare beneficiaries, totaling 1,335 services with total Medicare billing of $86,432. Data is available for 3 years (2020–2022), covering 19 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Stow, OH
- Active Since 06/16/2006
- Last Updated 09/12/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1225072325
Products in Payments
- APLENZIN (Drug) $57.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.